Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1540840
PUBLISHER: IMARC | PRODUCT CODE: 1540840
Choroidal Neovascularization Market Report by Product Type, Diagnosis (Fluorescein Angiography, Indocyanine Green Angiography, Spectral Domain Optical Coherence Tomography, and Others), Treatment Type, Application, and Region 2024-2032
PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global choroidal neovascularization market size reached US$ 6.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.4% during 2024-2032.
Choroidal neovascularization (CNV) refers to the creation of new blood vessels in the choroid layer of the eyes affecting the Bruch's membrane and retinal pigment epithelium (RPE). Its symptoms include lipid exudation, subretinal blood and fluid, and distortion, waviness and black spots in the central vision. At present, a combination of procedures, such as fluorescein angiography (FA), indocyanine green (ICG) angiography and optical coherence tomography (OCT) scanning, are utilized for diagnosing CNV. As per the results, doctors then prescribe anti-vascular endothelial growth factor (VEGF) drugs, thermal laser treatment and photodynamic therapy (PDT), to prevent the growth of the blood vessels.
The market is experiencing growth on account of the rising prevalence of age-related macular degeneration (ARMD), ocular histoplasmosis, pathologic myopia, angioid streaks, choroidal tears and inflammatory diseases of the choroid and retina. Moreover, the increasing geriatric population, which is more vulnerable to serious health conditions, is acting as another key factor bolstering the market growth. Furthermore, the growing adoption of combination drugs, along with the introduction of long-lasting anti-VEGF drugs, is propelling the demand for CNV treatments worldwide. Other factors, such as improving healthcare infrastructure and the increasing investments in research and development (R&D) activities, are also contributing to the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global choroidal neovascularization market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, type of diagnosis, treatment type and application.
Breakup by Product Type:
Intravenous
Intravitreal
Breakup by Type of Diagnosis:
Fluorescein Angiography (FA)
Indocyanine Green (ICG) Angiography
Spectral Domain Optical Coherence Tomography (OCT)
Others
Breakup by Treatment Type:
Angiogenesis Inhibitors Injection
Photodynamic Therapy
Laser photocoagulation
Low-dose Radiation Therapy
Surgery
Breakup by Application:
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Bausch Health Companies Inc., Bayer AG, Gilead Sciences, Inc., F. Hoffmann-La Roche AG, MaaT Pharma, Novartis AG, Pfizer Inc., Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited), Regeneron Pharmaceuticals Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.).
Key Questions Answered in This Report:
- How has the global choroidal neovascularization market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global choroidal neovascularization market?
- What are the key regional markets?
- What is the breakup of the market based on the product type?
- What is the breakup of the market based on the type of diagnosis?
- What is the breakup of the market based on the treatment type?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global choroidal neovascularization market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112024A2561
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Choroidal Neovascularization Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Intravenous
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Intravitreal
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Type of Diagnosis
- 7.1 Fluorescein Angiography (FA)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Indocyanine Green (ICG) Angiography
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Spectral Domain Optical Coherence Tomography (OCT)
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Treatment Type
- 8.1 Angiogenesis Inhibitors Injection
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Photodynamic Therapy
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Laser Photocoagulation
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Low-dose Radiation Therapy
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Surgery
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Application
- 9.1 Extreme Myopia
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Malignant Myopic Degeneration
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Age-Related Developments
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Bausch Health Companies Inc.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 Bayer AG
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Gilead Sciences, Inc.
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 F. Hoffmann-La Roche AG
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 SWOT Analysis
- 15.3.5 MaaT Pharma
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Novartis AG
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Pfizer Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.7.4 SWOT Analysis
- 15.3.8 Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Regeneron Pharmaceuticals Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.1 Bausch Health Companies Inc.
Product Code: SR112024A2561
List of Figures
- Figure 1: Global: Choroidal Neovascularization Market: Major Drivers and Challenges
- Figure 2: Global: Choroidal Neovascularization Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Choroidal Neovascularization Market: Breakup by Product Type (in %), 2023
- Figure 4: Global: Choroidal Neovascularization Market: Breakup by Type of Diagnosis (in %), 2023
- Figure 5: Global: Choroidal Neovascularization Market: Breakup by Treatment Type (in %), 2023
- Figure 6: Global: Choroidal Neovascularization Market: Breakup by Application (in %), 2023
- Figure 7: Global: Choroidal Neovascularization Market: Breakup by Region (in %), 2023
- Figure 8: Global: Choroidal Neovascularization Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 9: Global: Choroidal Neovascularization (Intravenous) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Choroidal Neovascularization (Intravenous) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Choroidal Neovascularization (Intravitreal) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Choroidal Neovascularization (Intravitreal) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Choroidal Neovascularization (Fluorescein Angiography) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Choroidal Neovascularization (Fluorescein Angiography) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Choroidal Neovascularization (Photodynamic Therapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Choroidal Neovascularization (Photodynamic Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Choroidal Neovascularization (Laser photocoagulation) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Choroidal Neovascularization (Laser photocoagulation) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Choroidal Neovascularization (Surgery) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Choroidal Neovascularization (Surgery) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Global: Choroidal Neovascularization (Extreme Myopia) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Global: Choroidal Neovascularization (Extreme Myopia) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Global: Choroidal Neovascularization (Age-Related Developments) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Global: Choroidal Neovascularization (Age-Related Developments) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: North America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: North America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: United States: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: United States: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: Canada: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: Canada: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: Asia Pacific: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: Asia Pacific: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: China: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: China: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: Japan: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: Japan: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: India: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: India: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: South Korea: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: South Korea: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: Australia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: Australia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: Indonesia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: Indonesia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Europe: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Europe: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Germany: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Germany: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: France: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: France: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: United Kingdom: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: United Kingdom: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: Italy: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: Italy: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: Spain: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: Spain: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Russia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Russia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Latin America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: Latin America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Brazil: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 78: Brazil: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Mexico: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 80: Mexico: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 81: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 82: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 83: Middle East and Africa: Choroidal Neovascularization Market: Sales Value (in Million US$), 2018 & 2023
- Figure 84: Middle East and Africa: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 85: Global: Choroidal Neovascularization Industry: SWOT Analysis
- Figure 86: Global: Choroidal Neovascularization Industry: Value Chain Analysis
- Figure 87: Global: Choroidal Neovascularization Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Choroidal Neovascularization Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Choroidal Neovascularization Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
- Table 3: Global: Choroidal Neovascularization Market Forecast: Breakup by Type of Diagnosis (in Million US$), 2024-2032
- Table 4: Global: Choroidal Neovascularization Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
- Table 5: Global: Choroidal Neovascularization Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 6: Global: Choroidal Neovascularization Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 7: Global: Choroidal Neovascularization Market Structure
- Table 8: Global: Choroidal Neovascularization Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.